Клиническое значение полиморфизма генов ренин-ангиотензиновой системы при нефротическом синдроме у детей
Диссертация
Впервые у детей с НС проведен комплексный анализ полиморфизма генов РАС м получены данные о распределении полиморфных маркеров гена АПФ (I/D), гема ангнотензиногена (АТГ) (М235Т и Т174М) и гена рецептора АТП 1-го типа (ATI-R) (A! L66С). Результаты молскулярно-генетического исследования свидетельствуют о наличии ассоциации М235Т полиморфизма гена АТГ и АНббС полиморфизма гена AT1-R с развитием НС… Читать ещё >
Список литературы
- Андреева М.Г. Роль полиморфизма TI74M гена ангиотензнногсна в формировании предрасположенности к артериальной гнпертензии,// Аатореф. днсс, .к, м. н,-2003
- Баранов А.А. Клинические рекомендации по педиатрии.//2005 Москва, -С 107−112.
- Барац С.С., Закроем AT. Днастолическая дисфункция сердца по показателям трансмнтрольного кровотока и потока в легочных венах: дискуссионные вопросы патогенеза, терминологии и классифи каци и Л Кардиология-1998.-№ 5. -С .69−76
- Бондаренко Б.Б., Зима Ю. Б. Телмнсартан новый блокатор рецепторов ангнотензнна 117/ Артериальная 1ипертензия.-Т-№ 8.-С. 82−84
- Вознанов А.Ф., Майданннк В. Г., Видный В. Г., Багдасарова И. В. Основы нефрологии детского возраста.// Киев. «Книга плюс».- 2002-С.46−72
- Гинтер Е.К. Эволюция представлений о генетической природе мультнфакториальиых заболеваний.// Мед, генетика.-2003.-Т, 2,-№ 41.-<146−155
- Гогин Е.Е. Гипертоническая болезнь.// Мое ква -1997.-С, 186−202
- Гомазков О. А- Пептиды в кардиологии.// Биохимия. Физиология, патология. Информация. Анализ. -2000. -М.*. «Материк Альфа».-С. 143−145
- Двойрнн В.В. Методы эпидемиологических исследований при злокачественных опухолях.// Москва, «Медицина».-1975.-С. 376−385
- И. Игнатова М. С. Патология органон мочевой системы у детей (современные аспекты).// Нефрология и дналнэ.-2004.-Тб.-№ 2.-С. 127−131
- Кадиев P.P., Будайчнева А.Б, Алдашев А. А., Миррамимов М. М. Полиморфизм гена ангиотензин-превращающего фермента у больных хроническим гломерулонефритом.// Нефрология и диалнз.-2004.-Т.6-N* 4.-С. 17−19
- Камышова Е.С., Кутырнна И. М., Носиков В. В., Швецов М. Ю. Значение полиморфных маркеров генов вазоактнвных гормонов в оценке клинических особенностей хронического гломерулонефрнта7/ Тер. архив.-2005.-№ 6.-С. 16−20.
- Картам ышева Н. Н. Чумакова Q.B. Некоторые механизмы формирования тубулоиктерстнцнального компонента при хронических заболеваниях почекЛ Нефрология и диализ.-2001.-T3. -Jfe3.-C.314−318
- Картам ышева Н. Н. Чумакова О.В., Кучеренко А. Г-, Сергеева Т, В. Прогрсссирование хронического гломерулонефрнта: клннико-морфологическне взаимосвязи.// Нефрология и диализ. -2003.-Т.5.-J*4.-C, 395−398
- Конькова Н. Е, Бургал А. Длин В. В, Современные представления о ренни-ангиотензи новой системе н ее роли в регуляции артериального давления.// Нефрология и дналнз.-2001.-Т-3--.№ 2.-С. 243−248
- Коеянкова ТВ., Еремнна Е. Р., Пузырсв В. П., Салюков В, Б, Полиморфизм TI74M гена ангиотензнногена в сибирской популяцннУ/ Генстнка.-2006.-Т.36.-№ 3 .-С.367−370
- Кутырнна И М-, Тареена И. Е., Носиков В, В. н др, Изучение полиморфизма гена ангнотензинпревращающего фермента при хроническом гломерулонефрите.//Тер, архив,-1999,-№ 6.-С. 30−34
- Кутырнна М.И. Применение ингибиторов ангиотензнн-превращакэщего фермента при первичных поражениях почек идиабетической нефропатииУ/ Consilium Medicum.-2002.-T. 4.-J6 7,-СЗЗ1−333.
- Матксрнмов Д.А. Эффективность плазмафереш, гемосорбцин н пульс-терапии метил преднизалоном, а комплексном лечении первичного гломсрулонсфрита у детей Л Днсс, канд.мед.наух. М.-1992
- Мустафнна О.Е., Тхаркахова З. Н., Бнкмеевэ A.M. н лр. Полиморфизм гена ангиотензннпреврашаюшего фермента и риск мультнфакторнальных заболеваний.// Мед. генетнка.-2002.-Т.1.-№ 5.-С212−220
- Мухин ПЛ., Козловская J1.B., Кутырина ИМ, Швецов М. Ю" Фомин ВВ. Протсинурнческое ремоделированне тубуланнтерстииия -мншень нефропротективной терапии при хронических заболеваниях почек.// Тф. архив--2002.-.-С.5−11.
- Напаян А.В., Архипов В. В., Берсснева Е. А. Маркеры функции почек и оценка прогресснровання почечной недостаточности.// Тер, архнв.-2004.-J&-4.C. 83−90
- Папаян А.В., Савенкова Н. Д. Клиническая нефрология детского возраста.// С-Петербург,-1997.-С.75−96
- Ратова Л.Г., Чазова И. Е. Нефропротективный эффект антнгн пертензивяой терапии: исследование ИРИС.// Consilium medicum.-2004.-№ 2.C.3−7
- Савенкова Н.Д., Папаян А.В, Нефротнческий синдром в практике педиатра.// Руководство для врачей. С-Пб.: Эскулап,-1 W9.-C.256 297
- Сергеева TJ3. Значение биопсии почки в диагностике гломерулонефрита у детей.// Материалы I конгресса «Современные методы диагностики и лечения иефро-урологическнх заболеваний у детей». Москва.¦ 1998.-С.79−81
- Сергеева Т.В. Цыгнн А.Н, Т Вознесенская Т. С, Чумакова О. В., Комарова О. В., Кутафина Е. К. Лечение гломерулонефрита у детей.// Пособие для врачей. M.-200I.C.6−22
- Сидоренко Б.А., Преображенский Д. В. Блокаторы АТ1-ангкотензнновых рецепторов.// Москва.-2001.-С.7−32
- Скобелева И.А., Васина ВЛ4., Волкова М. В. и др. Полиморфизм ДНК в области генов апо-В100* ano-СШ, аио-Е ангнотензинпревращающего фермента и показатели лннндного спектра у детей и подростков С-Петербурга^/ Молек. Генетика, -1997.-4.С.36−40
- Спиридонова М. Г, Степанов В. А., Пузырен В. П. Карпов Р.С. Анализ генных комплексов подверженности к коронарному атеросклерозу У/ Генетика-2002.-Т38,-№ З.-С.З 83−392
- Стсфанн ДВ., Всльтнщев Ю.Е Клиническая иммунология и иммунопатология детскою возрастав/ Руководство для врачей. М.-Мсдниина -1996.-С 384 427
- Студеинкин М.Я., Наумова В. И. Гнатюк А. И. и др. Классификация гломерулонефрита у детей.// Педиатрия, — 1977.-№ 2.-С.З-8
- Тареева И. Е, Нефрология.// Руководство для врачей в 2 т. М.-Мелнцина ¦ 1995.-Т.2.С.332−342
- Тареева И.Е., Кутырина И. М., Николаев А. Ю., Лнфшнц ИЛ., Швецов МЮ. Пути торможения развития хронической почечной недостаточности.// Тер. архив.-2000.-К" 6.-C.9-I4
- Тихомиров Е. Е, Пенелис В. Г., Басаргина Е. Н., Березнева НА. Аллельные варианты генов реннн’ангиотензкн-альдостероновой системы и кардномнолатин у детей Л Вопросы современной педиатрии. -2005.-№ 4.С.7−10
- Фролов Б.А. Физиология и патология обмена натрия и воды в организме.// М. «Меднцина».-2004.-СЛ31−137
- Чистяков Д.А., Туракулов Р, Н" Моисеев B.C., Носиков В. В. Полиморфизм Т174М гена аигнотензниогена и сердечно сосудистые болезни, а московской популяции при гипертонической болезни.// Генетика--1999 -TJ5.-№ 8.-СЛ 160−1164
- Чистяков Д А. Чугунова Л, А., Шамхалова М. Ш., Шестэкова М, В" Миленьхая Т. М. и др. Полиморфен гена сосудистого рецептора ангиотензнна II и мнкроангнопэтин при инсулннзавнсимом сахарном диабете.// Генетика -t999.-T.35,-Jft 9.-С. 1289−1293
- Шабалов Н.П. Нефритический синдром.// Детские болезни.-З ИЗД.- С-Петерб-1993-С.365−374
- Шадрина М И. Сломннский П-А., Мнлосердова О. В" Перова Н. В., Лнмборская С, А. Анализ полиморфизма гена ангиотензнннревращающего фермента у больных ишемической болезнью сердца в московской популяции.// Генетика,-2001.-Т37,-№ 4.-С.540−544
- Шахнйвнч P.M. Полиморфизм гена, концентрация к активность АПФ при различных формах ИБС-// Дисс. канд. мед. наук -1999
- Шснман Д. А. Патофизиология почки// Санкт-Петербург-2001,-С. 44−59
- ШулутКО Б. И. Артериальная пшертетия.// С-П-, PEHKOP.-200l.-C, 98−108
- Шулупга Б.И. Нефрология. // Ренкор-2002.-С210−220
- Шутов A.M., Ивашкина Т. Н. Куликова Е.С., Кондратьева Н. И. Рсмоделирование сердца у больных с хронической почечной недостаточностью в стадии, не требующей диализа-// Тер. архив,-2000.- 6.С.46−49
- Abbale М., Benigrn A., Bertant Т., Remuzzi G. Nephrotoxicity of increased glomerular protein traffic.// Nephrol.Dialys.TransplanL-1999. V. 14. P.304−312
- Abibol CL" Zilleruelo G., Freundlich M, Strauss J. Quantitation of proteinuria with urinary protein/creaiininc rations and random testing with dipsticks in nephrotic children^/ J, Pediatr.-l990.-V, t 16.-P.243−247
- Agerhotm-Larsen B, Nordestgaard В., Tybjaerg-Hansen A, ACE gene polymorphism in cardiovascular disease Meta-analisis of small and large studies in whites Ji AnnosclcrTromb.Vasc.Biol.-2000.-Vol, 20.-P. 484−492
- Al-Eisa A., Haider MX, Strivastva B.S. Angiotensin converting enzyme gene insertion/deletion polymorphism in idiopathic nephrotic syndrome in Kuwaiti Arab children.//Scand J, Urol, Nephrol,-2001, — V.-35.-P239−242
- Alvarez R" Reguero J, Batalla A, et al. Angiotenstn-con verting enzyme and angiotensin!) receptor 1 polimorphism: associstion with early coronary disease. //Cardiovasc. Res.-1998.-Vol .40.-P.375−379
- Anderson ?., Retuike HG., Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive тепа! disease associated with systemic hipenension in the mJI Clin. Invest-1986.-V. 77.P. 1993−2000
- Ameil G, Management of the nephrotic sindrom in the child.// In. Clin.Paediatric.Ncphrology. Ed. Liebcrman, Toronto -1976 P. 146−454
- Bagga A, Vasudev A.S., Moudgil A., Srivastava R.N. Peripheral blood lymphocyte subseis in idiopathic nephrotic syndrome of childhood,// IndianJ. Med Res.-1996.-Vol.104.-P.292−295
- Baldwin A.S. The transcription factor NF-kB and human disease // J. Clin. In vest,-2001 .-V. I07.-P.3-I I
- Banti* C., I vena K., Kreusser W. T Koch M. T Klein-Vehne N., Grahensee В. Hccring P. Influence of gcnetic polymorphisms of renin-angiotensin system on IgA nephropathy.// Am.J.Ncpbrol.-2004r-Mar-Apr,-V. 24<2).P, 258−67
- Barley J, Blackwood A" Miller M ct al, Angiotensin converting enzime gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples// J.Hum.Hypertens.- 1996.-VoLlO (l).-P.31−35
- Berge K. Berge H. Cardiovascular risk factors in people with different genotypes in the insertiotvrdeletion (I/D) polymorphism at the locus for angiotensin l-converting епгуте (ACE)// Clin. Gcnet -I997/-V.S2.-P, 422 426
- Bonnardcaux A., Davies E., Jeunemaitre X., Fery I., Charm A., Clauser E., Tiret L., Cambien F., Corvol P., Soubrier F. Angiotensin II type 1 receptor gene polymorphisms tn human essential hypertension.// Hypertension. -1994,-V.24.-P.63−69
- Border W.F., Nohl N.A. Inieraktions of transforming growth factor-^ and angiotensin II in renal fibrosis.// Hipcrtensions.-l998.V.3I.-P.18l-188
- Borel J.F. Mechanism of action of cyclosporin A and rationale use in nephrotic syndrome// Clin.Nephrol.-199L-V.35.-SuppL: S23−30
- Botto M" Dell Agnola C., Bygrave A.E., Thompson E.M. Cook Т., Pctry F. Loos M, Pandolfi P.P., Walport M.J. Homosygous Clg deficiency causes glomerulonephritis associated with multiple apoptppic bodies// Nai Genet.-1998.-V. 19.-P. 56−9
- Boutc N, Gribouval O. Rosclli S et в. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.//Nature GcncL-2000/- V.24-P149−354
- Brenner BM, t Cooper THE-, de Zecuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.// N.EngJ.Med.-2001.-V.345.-P.861- 869
- British Assosiation for Paediatric Nephrology. Consensus statement on management and audit potential for steroid responsive nephrotic syndrome.// Arch XHs.Child.-1994.-V.70.-P. 151−157
- Brodehl J. Conventional therapy for idiopatic nephrotic syndrome7/ Clin. NephroL-1991 .-V.35.-(Suppi. I), S.8−15
- Bnrnner F.P., Thiel G-, Hermte M. et al, Long term enalapril and verapamil in rats with reduced renal mass.// Kidney Int.-1989.-V.36,-P, 969−977
- Buraczynka M, Grzebalska A, m, Spasiewicz D., Orlowska G. t Ksiazek A. Genetic polymorphisms of renin-angiotensin system of interstitial nephritis.// Ann. Univ. Mariae Curie Sclodowska (Med).-2002.-V.57(2).-P330−6
- Cambien F. t Poirier 0. t Lecerf L.(Evans A., Cambou J.P., Arveiler D., Luc G. eual. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction.// Nature.- 1992.-V359.-P64I-644
- Cameron J, S, Focal segmental glomerulosclerosis in adults.// Nephrol. Di al, Transplant.-2003,-V, 18,-SuppI 6,-P, 45−51
- Caul field M., Lavender P., Farral M. et al. Linkage of the angiotensinogen gene to essential hypertension.// N.EnglJ.Med.-l994.- VJ30.-P.I629−1633
- Cbmow K.M. Pascoe L, White DC. Genetic analisis of the human type-1 angiotensin II receptor.// Mol. EndocrinoL-1992.-V.6,-PJ 113−1118
- SI. Cohen GJ., Pietrolungo J J7., Thomas J.D., Klein A. L, A practical guide to assessment of ventricular diastolic function using Dopptcr echocardiography.//J. Am, Coll.Cardiol.-1996.-V.27.-P. 1753−1760
- Cohen-Solar A. Left ventricular diastolic dysfunction: pathophysiology diagnosis and treatment. Nephrol Dial Transplant 1998- 13 (Suppl.4):3−5
- Couscr W.G. Pathogenesis of glomerular damage in glomeruloncphritisi/Ncphrol Dsal. Transplant-1998 -Vol. 13(1)-P. I CM 5
- Damico G, Bazi C. Patophysiology of proteinuria.// Kidney lnt.-2003-V.63.- P809−825
- Daniel V., Trautmann Y., Konrad M, Nauir A, Scharer K. T-lymphocyte populations, cytocins and other growth factors in serum and urine of children with idiopathic nephrotic syndrome.// Clinical. Nephrology.-1997.-V.47.-P.289−297
- David S. Biancone L, Caserta C, Bussolati B, Cambi V. Camussi G: Alternative pathway complement activation induces proinflammotory activity in human proximal tubular epithelial cells.'/ Nephrol.Dial. Transplant. -I997.-V.I2. -P.51−56
- Davies E. Bonnardeaux A., Lathrop G.M. et al. Angiotensin 11 (type-!) receptor locus: CA repeat polymorphism and genetic mapping.// Hum. Mol. Genct -1994.-V3.-P.83 8−842
- Dicp Q.N. Li J. S-. Scbiflnn EL, In vivo stady of ATI and ATII angiotensin receptors in apoptosis in rat blood vessels// Hipertension.1999.-V.34,-P, 617−624
- Dixit M., Mansur A., Dixin N., Oilman J., Santarina L" Glicklich D. The role of ACE gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis.//! .Postgrad.Med.-2002.-V.48 -P.266−269
- Donadelli R, Abbate M, Zanchi C, Coma D. Tomasoni St Benigni A, Remuzzi G, Zoja C. Protein traffic activates NF-kB gene signaling and promotes MCP-1 dependent interstitial inflammation// AmJ. Kidney Dis, 2000.-V.36.-P. 1226−1241
- Doria A., Ji L., Warram Jit, Krolcwsky A.S.Dde. I polymorphism in ihc AGTRJ gene.// Hum.Mol.Genet.-1994.-V3.-P. 1444−1447
- Dona A" Warram 1, Krolewski A. Molecular characterization of a DDE! melting polymorphism at the angiotensin 1-con verting en/imc (ACE) locus 7/ Hum. MuiaL-1994.-V.4(2).- P. 155−157
- Egido J. Vasoactive hormones and renal sclerosis.// Kidney Int.-1996.-V.49.-P.578−597
- Esther C" Howard Т., Marino E. et al/ Mice tacking angiotensin-canverting ensyme have low blood pressure, renal pathology, and reduced male fertility Jt Lab. Invest.-1996 Vol4{2).-P. 155−157
- Essen G.G., Rensma H.L., Zeeuw D-, Sluiter W. J. and al. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy Ji The Lancet. 1996 — V347-P.94−95
- Eyries M., Michaud A., Deinum J. et al. Increased shedding of angiotensin-convcrting enzyme by a mutation identified in the stalk region J1/ J .Biol.Chcm.-2001 .-V.276(8).- P.2I 1−214
- Feurten G, Mihatsch Mi. Risk factors for cyclosporin-induced nephropathy in patients with autoimmune disease-// N. Engl J.Med- -I992.-V.326,-P.1654−1660
- Fogo A. Progression and potential regression of glomerulosclerosis.// Kidney Int -1993.-V.59-P.804−819
- Frank СHerrmann M, Fernandez S, et al. Dominant T-cells in idiopathic nephrotic syndrome of childhood.// Kidney Int.-2000.-Vol. 57(2).-P.510−517
- Fuchshuber A+ Jean G, Gribouval О et al. Mapping a gene (SRNI) lo chromosome Ig25-g3i in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis.// Hum.Mol.GencL- 1995.-V.4.-P.2I55−2I58
- Fuchshuber A" Mehls O, Familial steroid-rcsistent nephrotic sindromcs: recent advances J1/ Ncphrol.Dial.Transplani-2000.-V.15.-P, 1897−1900
- Fujikawa T. f Ikegami H" Kawaguchi Y- ct al. Meta-analysis of association of insert ion/deletion polymorphism of angiotensin I- converting enzyme gene with diabetic nephropathy and retinopathy7/ Diabetologia. -1998,-V.4I (I).- P.47−53
- Garin E.H. Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome// Pediatr.Nephrol.-2000.-VoU4(8−9).-P.872−878
- Hamaguchi et al// Abstract.- J.Soc.Nephrol.-J995.-V.6. -P.389
- Hannu Jalanco. Patogenesis of proteinuria: lessons Icarnid from nefrin and podocinJt Pediatr. NephroU2003.-V.18.-P, 487−491
- Hcslan Ш., Branellec AJ-, Pilatte Y. et al. Differentiation between vascular permeability factor and 1L-2 in lymphocyte supematants from patients with minimal-change nephrotic syndrome,// Clin.Exp.Immunol.¦-1991 .-VoL86(1).-P. 157−162
- Bill P-A-, Lan H.Y., Nikolic Peterson DJ" Atkins R.C. The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis,// Kidney Int.-1994.-Vol .45(3).-P.7Q0−708
- Hingorani A., Jia H" Stevens P. et al. Blood pressure response to angiotensin converting enzyme inhibition: effect of age genotype.// Clin, Sc.- I995.-V.S9.-P.1−2
- Hiraia E., Iwano M., Hirayama T, el al Rapid measurement of urinary 1L-6 by ELISA: urinary IL-6 as a marker of mesangial proliferation^/ Nippon. Jinzo.GakkaiShi.-1994.-Vol.36(1).-P.33−37
- Hixson J.E. Powers P.K. Detection and characterization of new mutations in the human angiotensinogen genej1/ Hum. GeneL-1995. -V.96.-P.110−112
- Hohenfellner K. r Wingen A M., Nauroth O., Wuhl E-, Mehls O., Schaefer F., Imped of АСЕ I/D gene polymorphism on congenital renal malformations,// Pediair. Ncphrol.-20(c)L-Vol, t6.-P.3S6−36l
- Hon C., Harioka M" Yoshikawa N., Tsuzuki K, Yohida Y., Yoshicka EC, Fuji&awa K., Tsukahara H., Ohshima Y" Mayumi M.//Significance of ACE genotypes and medical treatments in childhood focal glomerusclerosis. Nephron.-2001 ,-V. 88.-P J13−319
- HuJton S.A., Shah V., Byrne M. R et al. Lymphocyte stibpopuJafions, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome,// Pediatr. Nephrol.-1994.-VoL8(2).-P. 135−139
- П9. Hunley Т.Е., Julian B. A-, Phillips JA. et al. Angiotcnsin-converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy,// Kidrvey Int. -1996.-V 49.-P.571−577
- Ikoma M-, Kawamura Т. Kkinuma Y., Fogo A, Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions// Kidney Int.-1991 .-V.40.-P. 195−202
- International Stady of Kidney Disease in Children. Minimal-change nephrotic syndrome in children: deaths during the first 5 to!5 years of observation// Pediatrics.-1984.-P.255−9
- Ishidoya S, Morrissey J, McCrakccn R. Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996- 49- 1110−9
- Jacobsen P, Tarnow Lr Carstensen B, Hovind P, Poirier O, Parving H. Genetic Variation in the Renin-Angiotensin System and Progression of Diabetic Nephropathy// J. Am, Soc.Nephrol.-2003.-V.14.-P2843−2850
- Jenemaitrc Soubtier F4 Kotelevtsev Y.V. et al. Molecular basic of human hypertension: role of angiotensinogen.// Cell.-1992.-V.71.-P.169−180
- Johnson R., Alpers C" Yoshimura A., Lombardi D. et al. Renal injury from angiotensin II-mediated hypertension// Hipertension -1992.-V. 19.-P.464−474
- Kagami S^ Kuhara Т., Okada K., Kuroda Y. Border W., Noble N. Dual effects of angiotensin U on the plasminogen/plasmin system in rat mesangial cells// Kidney InL-I997.-V.5l .-P.664−71
- Kamitani A. Raakugy H. Higaki J. et al, F-nhanced predictability of myocardial infarction in Japanese by combined genotype analysis// Hypertension -1995.-V.25.- P 950−953
- Kaneto H.> Morrisscy J" McCreaken R" Reyers A" Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney-// Kidney Int. -1994.- V.45.-P.I 637−47
- Kaplan J. M-, Kim H-, North K.N. et al. Mutation in ACTN4, encoding alpha-actin-4, cause familian focal segmental glomerulosclerosis.// Nature Genet.-2000.-V.24.-P.251−256
- Kario K., Vatsuo Т., Kobayashi H- Endothelial Cell Damage and Angiotensin-Converting Enzyme insertion/deletion genotype in Elderly Hypertensive Patients.// J. Am. Col l.Cardiol.-l 998.-V.32--P.444−450
- K"jaschki D. Caught flat-footed: podocytc damage and the molecular bases of focal glomerulosclerosis.// J, Clin, Invest-2001.-V, l08.-P.l583−1587
- Kestila M, Lcnkkcri U, Manrikko M et al. Positionally cloned gene for a novel glomerular prolcrn-ncphrin-is mutated in congenital nephrotic syndrome.// Mol Cel I.-1998 -V. 1 .-P.575−582
- Ketteler M., Noble N.A., Border W.A. Transforming faktor beta and angiotensin II- the missing glomerular hjpcrftliration tu glomerulosclerosis.// Annu Rev.PhysioI.-1995.-V.57,-P.279−295
- Kimura S., Mull ins JJ. t Bunnemmann B- ct al. High blood pressure in transgenic mice carrying the rat angiotensinogen gene.// EMBO J- -1992.-VJI.-P.821−827
- Klahr S, Schreiner G, Ichirawa I, The progression of renal disease.// N. Engl. J. Med.-3 988.-V, 19.-P.464−474
- Korbet S. M, Schartz M. M, Lewis E.E.: Primary focal segmental glomerulosclerosis: Clinical course and response to therapy 7/ Am.J.Kidney Dis.- 1994.-V.23.-P.773−783
- Lagrue G" Laurent J., Hirbec G., Ansguer J.C., Noirot C" Laurent G., Nebout Т." Kestenbaum S, Serum IgE in primary glomerular diseases.// Nephron -1984.-V.36.-P.5−9
- Lange К The future of nephrologic research- significance and urgent problems Л Clin. Nephrol.-1984.-V.21-P.82−5
- Lapinski R., Perico N. t Remuszi A" Sangalli F" Begnini A, Remuzzi G. Angiotensin II modulates glomerular capillar)' permsclectiviti in rat isolated perfused kidney//J. Soc. Nephrol, — 1996/-V 7-P 653−660
- Largo R" Comcz-Carrc D, t Soto К., Matron В., Blanco J. t Gazapo R.M., Plaza J.J., Egido J, Angiotensin-converting enzim is upregulated in the proximal tubules of rats with intense proteinuria// Hipertension, — 1999,-V, 33,-P, 732−739
- Lau Y.K., Woo K.T., Choong ML. et al. ACE gene polymorphism and disease progression of IgA nephropathy in Asians in Singapore// Nephron.-2002.-V.91 .-P.499−503.
- Lee D.Y., Kim W. t Kang SX* Koh G.Y., Park S.K. Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmental glomerulosclerosis.// Nephron,-1997.-V.77.-P.471−473
- Lee Y" Tsai J. ACE Gene Insertion/Deletion Polymorphism Associated with 1998 World Health Organization Definition of Metabolic Syndrome in Chinese Type 2 Diabetic Patients.// Diabetes Care.-2002, -V.25 -P. 10 021 008
- Lewis EJ., Hunsicker LG., Bain RP., Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy Л N. Engl. J. Med. -V329.-P. 1456−1462
- Lewis EI., Hunsicker LG., Clarke WR. et at. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropaty due to type 2 diabetes.// N.Eng. J. Med. -2001 -V.345 -P.851 -860
- Ling H" Vamvakas S., Schaefer L, Schnittler H,. Angiotensin II induced cell hypertrophy- Potential role of impaired proteolytic activity' in cultured LLC-PK| cells.// Nephrol, Dial. Transplant -1995.-VЛ 0.-P, 1305−12
- Lovati E" Richard A-, Frey В, M., Frey F.J. Ferrari P, Genetic polymorphisms of the rcmn-angiotensin-aldosnerone system in end-stage renal disease.// Kidney .m.-2001.-V, 60.-P.46−54
- Luther Y., Bantis C" Ivens K., Kolb-Bachhofen V. Heering P. Effects of genetic polymorphisms of the renin-angiotensin system on focal segmental glomerulosclerosis,// Kidney Blood Press. Res. -2003.-V.26 (5−6).-PJ33−337
- McLaughlin K.J.M., Harden P.N., Ueda S., Boulton-Jones J.M. et al, The role of genetic polymorphism of angiotensin-converting enzyme in the progression of renal diseases, //Hypertension.-1996.-V, 28.-P.912−915
- Marian AJ. Genetic markers: genes involved in human hipertension// J. Cardiovasc. Ri sc.-1997.-V.4(5).-P341 -345
- Maruyama K., Yoshida M, Nlshio H. t Shirakawa T. t Kawamura Т., Tanaka R., Nakamura H., Hyima K, Yoshikawa N. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy Л Pediatr. Nephrol-2001 -V. 16.-P.350−355
- Mcndoza S.A., Reznic VM., Griswold W.R. et al. Treatment of steroid-resistant focal glomerulosclerosis with pulse methy (prednisolone ami atcylating agents,// Pediatr. Ncphro1.-I990.-V, l (3).-P, 303−307
- Mezzano S-, Droguctt M., Burgos M., Ardiles L., Aros C. t Caor&i L, Tgido J, Overexpression of chemokines, fibrogenic cetokines, and miolibroblasts in human membranous nephropaty// Kidney InL-2000.-V.57,-P. 147−158
- Miner J. Focusing on the glomerular slit diaphragm.// Am. J. Pathol.-2002.-V. 160.-P.3−5
- Mizuiri S., Hemmi H." Inoue A. et al. Renal hemodynamic changes induced by captopril and angiotcnsin-convcrting enzyme gene polymorphism// Nephron. -1997 Vol.75.- P.310−314
- Montane В. Abitbol C" Chandar J. Strauss J., Zilleruelo O. Novel therapy of focal glomerulosclerosis with mycophcnolate and angiotensin blocade// Pediatr. Nephrol.-2003.-V, I8.-P.772−777
- Mundel P., Shankland SJ. Podocyte biology and responce to injuri// j. Am. Soc, Nephrol-2002-V.13.-P.3005−30I5
- Nakamura S" Nakamura L, Ma L., Vaugban D.E. Fogo A. Plasminogen activar inhibitor-l expression is regulated by the angiotensin type I receptor tn vivo.// Kidney Int.- 2000.-V.58.-P.251−259
- Niadct P. Habib R. Cyclosporins in the treatment of idiopathic nephrotic syndrome.1'/ J. Am. Soe. Nephrol-1994.~V.5-P. 1049−1056
- Niaudet P. The French Society of Pediatric Nephrology. Comparison of cyclosporin and chlorambucil in the treatment of steroiddependent idiopathic nephrotic syndrome- a multicentre randomized controlled trial.// Pediatr Nephrol.-1992.-V.6.-P. 1 -3
- Oktem F., Sirin A., Bilge I. Emre S" Agachan В., Turgau I. ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndromeJf Pediatr. Nephrol.-2004.-V. I9.-P.384−389
- Parving H-H., Lehnert H" Brochner-Mortenscn J" Gomis R, Andersen S., Arner P. The effect of irtoesartan on the development of diabeti nephropathy in patientes with t>'pe 2 diabetes.// N, Eng. J, Med,-2001.-V.345.-P. 870−878
- Patrakka У, Keatila M" Martiovaara J, Ruotsalaioen V, ct al- Congenital nephrotic syndrome (NPHSl): features resulting from different mutations in Finnish patients// Kidney lnt-2000-V, 58-P.972−980
- Patrakka J, Lahdenkari A" Koskimies O., Holmbcrg С et al. The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome// Pediatr. Res.- 2002.-V.52.-P.349−355
- Patrakka J., Ruotsalainen V., Reponen P. et at. Reccurence of nephrotic sindrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin// Transplantation.- 2002.-V.73.-P.394−403
- Pei Y." Cattaran D" Del more T. et al. Evidence suggesting undertreatmcnt in adults with idiopathic focal segmental glomerulosclerosis// Am, J. Med, — 1987.-V.82.-P.93 8−44
- Pei Y." Scholey J., Thai K., Suzuki M., Cattran D. Association of angioiensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients,//). Clin. Invest- 1997/-V.IOO-P. 814 820
- Ponticelli C, Glucocorticoids and immunomoduJating agents. In: Ponticelli C. t Glassock R., editors. Treatment of primary glomerulonephritis// New York- Oxford University Press-1977.-P.2 5−27
- Ponticelli C" Rizzoni G, F., Edefonti A. cl al. A randomized trial of cyclosporin in steroid-resistant idiopathic nephrotic syndrome// Kidney Int.-1993.-V.43 .-P. 1377−1384
- SB. Ruggenenti P., Perm A., Mosconi L. et al, Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies.// Ibid. -1998.-V.53.-P.1209−12I6
- Ruggenenti pr, Pcma A., Geradi G. Renal function and requirement for dialysis in chronic nephropathy patients in long-term ramipril: REIN follow-up trial.7/ Lancet.-1998,-V.352.-P. 1252−1256
- Ruiz-Ortega M, Egido J. Angiotensin II modullates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts,// Kidney Int.-1997.-VJ2.-P. 1497−1510
- Rullcdgc D.R., Browe C.S., Kubilis P. S., Ross E.A. Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans,// Am. J. Hypertens. -l994.-V, 7.-P.65l-654
- Schena F.P., СУ Attn С., Cerullo G, et al. ACE gene polymorphism and IgA nephropathy: An ethnically homogeneous study and a meta-analysis// Kidney Int -2001.-V.60.-P.732−740
- Schieppati A. and Remuzzi G. The future of rcnoprotection: frustration and promises J/ Kidney International, -2003,-V.64.-P, l947-l955
- Schmidt S, Ritz E. The role of I-converting enzyme gene polymorphism En renal disease, //Curr. Opin. Nephrol. Hypertens.-1996,-V.5,-P. 552−555
- Schmidt S" van Hooft IMS, Grobbe D.E. et al. Polymorphism of the angiotensin I converting enzyme gene and its predisposition to high blood pressure. // Hypertension/-1993.-V .21 .-P.455−460
- Schmist S., Sharma AM. Zilch O., Beige J" WaEla-Fnedel M, Gantcn D., Distler A-, Ritz E, Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset J I Nephrol, Dial, Transplant -1995,-V.I0,-P.I145−1148
- Schrier W, R. Renal and Electrolyt Disorders.// Philadelphia ¦ New York, -1997,-P, 640−68S
- Schunkert H" Hense H-W" Holmer SR., Stcndcr M, Pctz S" Keil U" Lorret ВН., Riegger GA. Association between a deletion polymorphism of angiotensin converting erisyme gene and left ventricular hypertrophy.// N. Engl. J. Med.-1994.-V.330,-P.1634−1638
- Schwartz M. M, Korbct S.M.: Primary focal segmental glomerulosclerosis: pathology, histologic variants and pathogenesis.// Am. J. Kidney Dis. -}993.-V2.-p, 874−883
- Schwant K-. Simons M" Reiser J" Salecm M., Faul C. and et Podocin, a raft-associated component of the glomerular slit diafragm, interacts with CD2Ap and nephrin// J. Clin, Invest. -2001 .-V.108.-P. 1621−1629
- Scrdaroglu E. t Mir S. Berdeli A., Aksu N^ Bak M. ACE gene insertion/deletion polymorphism in childhood idiopathic nephrotic syndrome JI Pediatr. Nephrol.-2005,-V.20,-P, 1738−1743
- Song J., Narita 1″ Goto S. et al. Gender specific association of aldosterone sinthase gene polymorphism with renal survival in patienies with IgA nephropatyV/ J. Med. Genet. -2003.-V.40.-P.372−376
- Stefanovic V. t Golubovic E, Mitic-Ztotkovic M. Larsen G.G., Thestrup-Pederscn K. Intcrleukin-12 and interferon-gamma production in chilhood idiopathic nephrotic syndrome.// Pediatr, Nephrol I998.-V.I2.-P.463−6
- Stratta P. Canavese C-, Ciccone G. et al. Angiotensin 1-converting enzyme genotype significantly affects progression oflgA glomerulonephritis in an Italian population.// Am J. Kidney Dis. -1999.-V, 33(6).-M071−1079
- Tamow L, Gambien F., Rossing P., Nielsen F" Hansen B. f Ricard S.(Poirier 0″ Parving H. Angiotensinogen gene polymorphisms in IDDM patiens with diabetic nephropathy.// Diabetes.-1996 Маг.-V.45(3).-P.367−369
- Tbaraux P., Cbatziantoniou C., Fakbouri F., Dussaule J. Angiotensin II activates collagen I gene through a mechanisms involving the MAP/ER kinase pathway Jt Hipertension-2000.-V.36.-P.330−336
- Tune B.M., Kirpekar R.Y., Sibley R.K. el al. Intravenous methylprednisone and oral alkylating agent therapy of prednisone* resistant pediatric focal segmental glomerulosclerosis: a long term follow-up.// Clin. Nephrol. -1995.-V.43-P.84−88
- Ulrich W. end al. Angiotensin 11 Inhances LPS induced inflamation in the kidney by upregulation of the toll-like receptor 47/ Abstract. Abstract book from the World Congress of Nephrology.-June 8−12, 2003, Bcrlin.-P.13−14.
- Unger Th, Pharmacological properties of angiotensin II antagonists: examining the therapeutic implications.// JRAAS.-200l.-V.2(Suppl, 2).-P.4−7
- Waldo F.B., Benfkld M.R., Kohaut E. C, Therapy of focal and segmental glomerulosclerosis with methylprednisolonc, cyclosporins A and prednisone.// Pediatric. Nephrol-1998.-V. 12.-PJ97−400
- Waldo F.B. Benfxeld M.R., Kohaut E.C. Methylprednisone treatment of patients with steroid-resistant nephrotic syndrome// Pediatr. Nephrol.-I992.-V.6.-P.503−507
- Walker W. G" Whelton PXt Saito H., Herman J. Relation between pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects// Hypertension -1979,-V.L-P.287−291
- Webb N., Lewis M., Igbat J. et al. Childhood steroid-sensitive nephrotic sindrome: does the histology matter?// Am, i. Kidney Dis.-1996.-V.27.-P.484−488
- Wetch T.R. McAdams AJ, Beischel L, S. Glomerulonephritis associated with complete deficiency of the fourth component of complement. Response to intravenous immunoglobulin// Arthritis Rheum.-I995.-V.38.-P. 1333−7
- Whiteside С., Prutis К., Cameron R, Thompson J. Glomerular epithelial dcicchment, not reduced charge density, correlates with proteinuria in adriamycin and puromicin nephrisis.// Lab. Invest. -1980.-V.61.-P, 650−660
- Winn MP., Conlon PJ., Lynn K.L. et al. Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 1I and further evidence of genetic heterogeneinyJ/ Genomics.-1999.-V.58.-P. 113−120
- Wolf G, Ziyadeb FN, Zahner G, Stahl RAK. Angiotensin II is mitogenic for cultured rat glomerular endothelial cells,// Hypertension.-1996,-V.27.-P.897−905
- Wolf G, Angiotensin II is involved in the progression of renal disease: importence of non-hemodinamic mechanisms.// Nephrologie.-1998.-V. 19.-P.451−456
- Wolf G., Haberstrah U., Neilson E.G. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells.// Am. J, Pathil, 1992.-V.140.-P.95−107
- Wolf G" Ncilscm E.G. Angiotensin II as renal growth factor// J, Am. Soc. Nephrol. -I993.-VJ.-P. I 531−1540
- Wolf G., Neilson E.G. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells.// Am. J. Physiol. -1990.-V.259-P.768−77
- Wolf G" Zahner G., Mondorf Schoeppe W. and al- Angiotensin II stimulates cellular hypertrophy of LLC-PKi cells through the ATj receptor,//Nephrol. Dial. Transplant. -I993.-V.8.-P. 128−33
- Woo К Т., Lau YX, Choong L.H., Tan H.B., Fook-Chong S" Tan E.K., Yap H.K., Wong K.S. Polymorphisms of renin-angiotensin system genes in IgA nephropathy7/ Nephrology (Carlton). -2004 Oct.-V.9(5).-P.304−9.
- ZoJa C-, Morigi M., Remuzzi G: Proteinuria and phenotypic change of proximal tubular cells// J, Am. Soc, Nephrol. -2003.-V.14.-P.36−41
- Zoja C^ Coma D. t Cammozi D.(Cattaneo D, et al, How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approuch//J. Soc. Nephrol. -2002.-V.I3.-P.2898−2908